Evaluation of Safety Information of the Foods with Function Claims Based on Adverse Event Reports in Information System on Safety and Effectiveness for Health Foods Database

被引:0
|
作者
Kobayashi, Etsuko [1 ]
Nishijima, Chiharu [1 ]
Sato, Yoko [1 ]
Chiba, Tsuyoshi [1 ]
机构
[1] Natl Inst Biomed Innovat Hlth & Nutr, Dept Food Funct & Labeling, Natl Inst Hlth & Nutr, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628636, Japan
来源
FOOD HYGIENE AND SAFETY SCIENCE | 2019年 / 60卷 / 04期
关键词
health food; adverse event; foods with function claims; labeling; GINKGO-BILOBA; BIFIDOBACTERIUM SEPTICEMIA; PRETERM INFANTS; BACTEREMIA; WARFARIN; THERAPY; PATIENT; RISK;
D O I
10.3358/shokueishi.60.119
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Foods with Function Claims are allowed to label health claims based on scientific evidence evaluated by the manufacturers. To prevent health problems caused by inadequate use, the manufacturers should label proper safety information. To evaluate whether safety information is sufficiently provided, we conducted the adverse event review focused on popular functional ingredients using the database; Information system on safety and effectiveness for health food. The data suggested that causal factor of adverse events related to products containing soy isoflavone, ginkgo biloba extract and docosahexaenoic acid/eicosapentaenoic acid were overdose intake, concomitant use with certain medicines, and use by whom with an allergic predisposition. However, the safety information on the label was insufficient to prevent adverse events on each products' label. It is important not only to encourage food manufacturers to provide sufficient information based on safety review, but also to inform consumers about adverse events.
引用
收藏
页码:119 / 125
页数:7
相关论文
共 50 条
  • [31] Development of foods with function claims based on the health benefits of tomato-derived nutrients
    Yoshida, K.
    Inoue, T.
    Aizawa, K.
    Suganuma, H.
    [J]. XVI INTERNATIONAL SYMPOSIUM ON PROCESSING TOMATO, 2022, 1351 : 241 - 247
  • [32] The European Information System for Occupational Safety and Health, EISOSH
    Korhonen, E
    [J]. ERGONOMICS AND SAFETY FOR GLOBAL BUSINESS QUALITY AND PRODUCTIVITY, 2000, : 165 - 168
  • [33] Evaluation of availability of information on risk factors in reports of adverse drug reactions in a pharmacovigilance database
    van Eijl, Dennis
    van Hunsel, Florence
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 221 - 221
  • [34] Optimized Flight Safety Event Detection in the National General Aviation Flight Information Database
    LaBella, Aidan P.
    Karns, Joshua A.
    Akhbardeh, Farhad
    Desell, Travis
    Walton, Andrew J.
    Morgan, Zechariah
    Wild, Brandon
    Dusenbury, Mark
    [J]. 37TH ANNUAL ACM SYMPOSIUM ON APPLIED COMPUTING, 2022, : 1570 - 1579
  • [35] A survey of veterinary professionals in Sweden: Adverse event reporting and access to product safety information
    Mount, James
    Sjostrom, Karin
    Arthurson, Veronica
    Kreuger, Sanna
    [J]. VETERINARY RECORD OPEN, 2021, 8 (01)
  • [36] Community Public Safety Evaluation System Based on Location Information Service Architecture
    Zhao, Zili
    [J]. MOBILE INFORMATION SYSTEMS, 2021, 2021
  • [37] The effectiveness of risk communication regarding drug safety information: a nationwide survey by the Japanese public health insurance claims data
    Hagiwara, Hiromi
    Nakano, Shun
    Ogawa, Yoshihiro
    Tohkin, Masahiro
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (03) : 273 - 278
  • [38] The study on evaluation for airline safety based on uncertain information
    Wang, Huawei
    Wang, Yanfeng
    [J]. PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE AND ENGINEERING MANAGEMENT, 2009, : 124 - 128
  • [39] New Insight on the Safety of Erenumab: An Analysis of Spontaneous Reports of Adverse Events Recorded in the US Food and Drug Administration Adverse Event Reporting System Database
    Maurizio Sessa
    Morten Andersen
    [J]. BioDrugs, 2021, 35 : 215 - 227
  • [40] New Insight on the Safety of Erenumab: An Analysis of Spontaneous Reports of Adverse Events Recorded in the US Food and Drug Administration Adverse Event Reporting System Database
    Sessa, Maurizio
    Andersen, Morten
    [J]. BIODRUGS, 2021, 35 (02) : 215 - 227